drugset / Trial / NCT02467413
BAC in Patient With Alzheimer's Disease or Vascular Dementia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to evaluate the efficacy of BAC patients with Alzheimer's disease or vascular dementia.The secondary objective of this study is to evaluate the safety of BAC patients with Alzheimer's disease or vascular dementia.
Timeline
- Start
- 2017-01-30
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
Outcome
Outcome not reported
Stopped (Enrollment): “The study was withdrawn before participants were enrolled.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BAC | Unknown | 30 g | Topical |